Dado oficial do INPI

Lundbeck institute

Sabia que essa marca já está registrada no Brasil?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Registro de marca em vigor (Madri)Tipo: MistaEscritório: Brasil

Ativar vigilância desta marca Falar com especialista

Snapshot rápido

ST13

BR500000501858073

Classe

5, 9, 16, 38, 41, 42

Pedido

501858073

Registro

501858073

Ver no INPI

Andamento no INPI

Depósito28/10/24
Publicação19/08/25
Exame
Deferimento24/03/26
Concessão28/04/26
Vigente28/10/34

Registro concedido em 28/04/2026 e em vigor até 28/10/2034, quando precisa ser renovado.

Proteção válida até:28/10/2034

Última movimentação publicada pelo INPI: 28/04/2026. Atualizamos a cada nova RPI, publicada semanalmente.

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação INPI

Registro de marca em vigor (Madri)

Tipo de processo

Pedido e registro

Eventos registrados

Atualização mais recente

28/04/2026

Tipo de marca

Mista

Classes Nice

5, 9, 16, 38, 41, 42

Data de depósito

28/10/2024

Data de registro

28/04/2026

Data de expiração

28/10/2034

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Natureza

Madri Produto/Serviço

Escritório responsável

Brasil

Tipo de titular

NÃO RESIDENTE

Localização do titular

Titulares e representantes

Titulares

H. Lundbeck A/S

Representantes

Licks AdvogadosVer perfil do escritório

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 16Classe 38Classe 41Classe 42

Códigos Vienna

27.5.25

Produtos e serviços

Classe 5

Pharmaceutical and medical preparations and substancespharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated from or acting on the central nervous systempharmaceutical preparations and substances acting on the central nervous systemcentral nervous system stimulantspharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseasespharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood swings, psychosis, anxiety, apathy, epilepsypharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and movement disorders, tremor, schizophrenia, bipolar disease and disorder, mania, ADHD, PTSD, agitation, aggression, autism, melancholia, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, drowsiness, nausea, migraine, pain, alcoholism and addictionpreparations, substances, reagents and agents for diagnostic and medical purposes

Classe 9

Electronic publications (downloadable), including books, reports, brochures, booklets, magazines, leaflets, magazines, journals, teaching and training material in research and development, science, disease information, clinical studies, tests and trials, diagnostics, medicine, pharmaceuticals, medical disorders, medical diseases, clinical or medical treatment and preventionsoftware for medical and pharmaceutical information, education and sales activitiessoftware for the analysis of medical and pharmaceutical information and disease informationsoftware, including application software for mobile devices (app)data processing and communication devices and instruments for information sharing and interaction in research and development, science, clinical studies, tests and trials, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and preventionelectronic publications (downloadable) related to magazines, journals, teaching and training material in research and development, science, clinical studies, tests and experiments, diagnostics, medicine, drugs, disorders, diseases, treatment and prevention, downloadable software, including application software for mobile devices (app)software for use in the diagnosis, management, monitoring, assessment, control and investigation of psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, convulsions, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholia, OCD, Tourette syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, migraine, pain, alcoholism and addiction

Classe 16

Printed publications, including books, reports, brochures, booklets, magazines, leaflets, magazines, journals, teaching and training materials in the field of research and development, science, clinical studies, tests and trials, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention

Classe 38

Providing online forums in the fields of medicines, disease awareness and treatmentsproviding online chat rooms and electronic message boards for the transmission of messages among users in the field of medicines, disease awareness and treatments

Classe 41

Educational services, namely conducting seminars in the field of pharmaceutical preparations and disease awarenessprovision of education in pharmaceuticals and disease awarenessarranging and conducting seminars, conferences, symposia, training workshops and courses in the field of medicines and disease awarenesseducational activities within pharmaceutical research and development, medical clinical examinations, pharmaceutical tests and trials and diagnostic medicine in connection with the treatment and prevention of diseases and disordersprovision of aforementioned services electronically, online, via cable or internet or other electronic mediaarranging and conducting expert forums, namely online training programs in the field of pharmaceutical preparationsproviding non-downloadable online publications, namely, books, reports, brochures, pamphlets, leaflets, patient information leaflets, magazines, journals, educational and training materials in the field of pharmaceutical research and development, science, medical clinical studies in the field of pharmaceutical testing and trials, diagnostic medicine, drugs, disorders, disease awareness, treatment and prevention related to assessment of cognitive functionseducation in the form of providing cognitive function assessment services through non-downloadable on-line screening tools

Classe 42

Pharmaceutical research and developmentscientific and technological services, namely, scientific testing and research related to medical disorders, medical diseases and medical preventionscientific and technological services, namely, scientific testing and research related to the central nervous system and central nervous system related disorders, pharmaceutical preparations and disease awarenessmedical and clinical research, namely pharmaceutical clinical research and conducting clinical trials for others in the field of pharmaceutical preparationsdiagnostic research and testing in pharmaceutical research

Publicações

Histórico de despachos e eventos da marca no INPI.

4 publicações encontradas

IPAS770

Concessão de registro em designação

RPI 2886

28/04/2026

IPAS768

Deferimento de designação

RPI 2881

24/03/2026

IPAS270

Deferimento da petição

Protocolo: 850250714974 (17/12/2025) Petição (tipo): Nomeação, destituição ou substituição de procurador [em processo de registro] (385.1) Requerente: H. LUNDBECK A/S Procurador: Licks Advogados Detalhes do despacho:Nomeado procurador Licks Advogados com poderes para representar o titular do processo perante o INPI.

RPI 2876

18/02/2026